The table below shows BeOne Medicines AG's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
$286.48M
$164.91M
$70.66M
Gross profit
$4.67B
$3.22B
$2.08B
$1.13B
$1.01B
-
R&D
$2.15B
$1.95B
$1.78B
$1.64B
$1.46B
$1.29B
SG&A
$2.08B
ONC annual revenue (10-K history)
BeOne Medicines AG reported annual revenue of $5.34B for fiscal year 2025. That is up 40.2% from $3.81B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.07M (FY 2016) to $5.34B. Figures come from the company's audited annual reports as filed with the SEC.